Unfortunately, this is from the New York Times, not the Onion. The new chemotherapy drug Folotyn costs $30,000 a month and there is no evidence it prolongs the lives of people taking it. I have seen few better examples of why much tighter federal regulation and insurance reform is urgently needed. When insurance companies (or [...]
Archive for December, 2009
When Drug Prices Approach Infinity
Posted in Uncategorized on December 5, 2009 |
Obesity Is Central To Dealing With Sleep Apnea
Posted in Uncategorized on December 5, 2009 |
Obese men put on a low-calorie liquid diet for seven weeks experienced substantial decreases in sleep apnea. In a randomized controlled trial, obese men who spent seven weeks on a very low-calorie liquid diet saw their sleep apnea drop from severe or moderate to mild or normal, according to Kari Johansson, a PhD candidate at [...]
Electronic Health Records Increase Quality But Fail to Lower Costs
Posted in Uncategorized on December 3, 2009 |
From Cleveland Clinic in Ohio, which along with the Mayo Clinic and Kaiser Permanente may constitute the best-case scenario for the success of electronic health records (EHR), comes word that EHR brings quality improvements but no cost savings after a $100 million investment. Likely bottom line: if the Cleveland Clinic can’t generate cost savings, it is likely that [...]
